Daiichi Sankyo News
Most Popular Daiichi Sankyo Story
Astellas scores highest in Japanese M&A bout
Japan’s biggest pharma players have been roaming the world in recent years in a restless search for new acquisitions. They've been looking for deals to put an extra oomph into their earnings. Read more...
Latest Headlines
- February 7, 2012
- February 3, 2012
- January 17, 2012
- December 21, 2011
- September 14, 2011
- July 1, 2011
- June 9, 2011
- May 24, 2011
- March 15, 2011
- March 11, 2011
- January 27, 2011
- November 16, 2010
- October 29, 2010
- September 3, 2010
- August 12, 2010
- July 30, 2010
- May 12, 2010
- March 30, 2010
- March 15, 2010
- March 12, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
